Show simple item record

dc.contributor.authorHattersley, Andrew
dc.contributor.authorShields, Beverley M.
dc.contributor.authorJones, Angus G
dc.date.accessioned2019-05-09T14:32:33Z
dc.date.available2019-05-09T14:32:33Z
dc.date.issued2019-03
dc.identifier.citationDennis JM [et al]. Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017. Diabetes, Obesity & Metabolism. 2019 Mar 3en_US
dc.identifier.pmid30828962
dc.identifier.doi10.1111/dom.13687
dc.identifier.urihttps://rde.dspace-express.com/handle/123456789/620995
dc.description.abstractAim To describe population‐level time trends in prescribing patterns of type 2 diabetes therapy, and in short‐term clinical outcomes (glycated haemoglobin [HbA1c], weight, blood pressure, hypoglycaemia and treatment discontinuation) after initiating new therapy.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.urlhttps://doi.org/10.1111/dom.13687en_US
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen_US
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen_US
dc.titleTime trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017en_US
dc.typeJournal Articleen_US
dc.identifier.journalDiabetes, Obesity & Metabolismen_US
dc.type.versionIn press (epub ahead of print)en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record